2025INSIGHTStudiesPreferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experimentREAD MORE
2025ODYSSEY TrialStudiesVirological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents:a secondary analysis of the ODYSSEY trialREAD MORE
2025StudiesWOMANPowerSafety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in UgandaREAD MORE
2024StudiesAdverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9–23 months old in Uganda, 2019–2020 — Preliminary reportREAD MORE
2024StudiesProportion of HIV exposed infants aged 0‑6 months that missed nevirapine prophylaxis in Mulago National Referral Hospital, Uganda: a cross‑sectional studyREAD MORE
2024PURPOSE 1StudiesTwice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender WomenREAD MORE
2024ICODAStudiesData challenges for international health emergencies: lessons learned from ten international COVID-19 driver projectsREAD MORE
2024PREPAREStudiesExploring the consent process among pregnant and breastfeeding women taking part in a maternal vaccine clinical trial in Kampala, Uganda: a qualitative studyREAD MORE
